- Home
- TEF vs BNTX Comparison
TEF vs BNTX Comparison
Compare TEF & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEF
- BNTX
- Stock Information
- Founded
- TEF 1924
- BNTX 2008
- Country
- TEF Spain
- BNTX Germany
- Employees
- TEF N/A
- BNTX N/A
- Industry
- TEF Telecommunications Equipment
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TEF Telecommunications
- BNTX Health Care
- Exchange
- TEF Nasdaq
- BNTX Nasdaq
- Market Cap
- TEF 24.9B
- BNTX 23.9B
- IPO Year
- TEF 1987
- BNTX 2019
- Fundamental
- Price
- TEF $4.04
- BNTX $113.77
- Analyst Decision
- TEF
- BNTX Strong Buy
- Analyst Count
- TEF 0
- BNTX 15
- Target Price
- TEF N/A
- BNTX $143.50
- AVG Volume (30 Days)
- TEF 804.6K
- BNTX 630.9K
- Earning Date
- TEF 11-07-2024
- BNTX 11-04-2024
- Dividend Yield
- TEF 7.93%
- BNTX N/A
- EPS Growth
- TEF N/A
- BNTX N/A
- EPS
- TEF N/A
- BNTX N/A
- Revenue
- TEF $45,249,832,683.00
- BNTX $3,390,698,192.00
- Revenue This Year
- TEF $1.62
- BNTX N/A
- Revenue Next Year
- TEF $0.01
- BNTX N/A
- P/E Ratio
- TEF N/A
- BNTX N/A
- Revenue Growth
- TEF 2.55
- BNTX N/A
- 52 Week Low
- TEF $3.82
- BNTX $76.53
- 52 Week High
- TEF $4.93
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- TEF 25.88
- BNTX 48.60
- Support Level
- TEF $4.45
- BNTX $109.52
- Resistance Level
- TEF $4.09
- BNTX $115.34
- Average True Range (ATR)
- TEF 0.06
- BNTX 4.35
- MACD
- TEF -0.04
- BNTX -0.72
- Stochastic Oscillator
- TEF 5.08
- BNTX 26.76
About TEF Telefonica SA
Telefonica operates mobile and fixed networks in Spain (where it is the incumbent telephone operator), the UK, Germany, Brazil, and other Latin American countries like Colombia, Mexico, Argentina, and Chile. The company derives more than 30% of its revenue from Spain, close to 20% from Germany, and 20% from Brazil. Its UK operations are held through a joint venture with Virgin Media. For several years Telefonica has been simplifying its corporate structure by selling noncore assets.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.